FDA 483 - Arnold Professional Pharmacy - March 18, 2022

Arnold Professional Pharmacy in Arnold, MD, was cited for significant deficiencies during an FDA inspection, primarily concerning cross-contamination risks and inadequate cleaning practices. Observations included the production of beta-lactam drugs without proper segregation and the use of non-dedicated, improperly cleaned equipment. Additionally, non-microbial contamination was found in the production area, and difficult-to-clean, damaged equipment was in use.